EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.45
(-0.68%)
AUD 1.45
(-0.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 39.57 Million AUD | 75.2% |
| 2023 | 22.58 Million AUD | 285.06% |
| 2022 | 5.86 Million AUD | -40.66% |
| 2021 | 9.88 Million AUD | 374.81% |
| 2020 | 2.08 Million AUD | -34.59% |
| 2019 | 3.18 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 6.9 Million AUD | -50.02% |
| 2024 Q2 | 13.06 Million AUD | 89.13% |
| 2024 Q4 | 26.51 Million AUD | 0.0% |
| 2024 FY | 39.57 Million AUD | 75.2% |
| 2023 Q2 | 8.76 Million AUD | 86.73% |
| 2023 Q3 | 7.14 Million AUD | -18.55% |
| 2023 Q1 | 4.69 Million AUD | 99.96% |
| 2023 FY | 22.58 Million AUD | 285.06% |
| 2023 Q4 | 13.82 Million AUD | 93.55% |
| 2022 Q1 | 1.43 Million AUD | -61.08% |
| 2022 FY | 5.86 Million AUD | -40.66% |
| 2022 Q4 | 2.34 Million AUD | 64.55% |
| 2022 Q3 | 1.42 Million AUD | -43.01% |
| 2022 Q2 | 2.5 Million AUD | 74.44% |
| 2021 FY | 9.88 Million AUD | 374.81% |
| 2021 Q2 | 5.38 Million AUD | 91.82% |
| 2021 Q3 | 2.04 Million AUD | -62.05% |
| 2021 Q4 | 3.68 Million AUD | 80.29% |
| 2021 Q1 | 2.8 Million AUD | 226.09% |
| 2020 Q3 | 546.59 Thousand AUD | -55.21% |
| 2020 Q4 | 861.68 Thousand AUD | 57.65% |
| 2020 Q2 | 1.22 Million AUD | 70.5% |
| 2020 Q1 | 715.78 Thousand AUD | 0.0% |
| 2020 FY | 2.08 Million AUD | -34.59% |
| 2019 FY | 3.18 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -484.598% |
| Biome Australia Limited | 7.91 Million AUD | -400.231% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -13125.504% |
| Biotron Limited | 5.11 Million AUD | -674.348% |
| Acrux Limited | 8.55 Million AUD | -362.859% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -69.073% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -6475.789% |
| BTC Health Limited | -1.03 Million AUD | 3909.162% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -100.201% |
| CSL Limited | 7.56 Billion AUD | 99.477% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 29.717% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | -26.448% |
| Immutep Limited | 42.87 Million AUD | 7.699% |
| Memphasys Limited | 3.67 Million AUD | -975.865% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | -21.034% |
| Noxopharm Limited | 7 Million AUD | -465.333% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -263.109% |
| Race Oncology Limited | 14.77 Million AUD | -167.929% |
| Starpharma Holdings Limited | 22.81 Million AUD | -73.45% |
| Tissue Repair Ltd | 6.66 Million AUD | -493.603% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -5472.158% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -1333.329% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -565.282% |
| Patrys Limited | 4.93 Million AUD | -702.187% |
| Orthocell Limited | 15.36 Million AUD | -157.486% |
| Imugene Limited | 135.09 Million AUD | 70.705% |
| PYC Therapeutics Limited | 60.91 Million AUD | 35.035% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -4335.882% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -255.771% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -266.93% |
| Nanollose Limited | 12.5 Thousand AUD | -316469.97% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -1082.779% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -1913.739% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -369.129% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -859.297% |
| Nyrada Inc. | 4.55 Million AUD | -768.781% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 85.303% |
| Dimerix Limited | 25.64 Million AUD | -54.327% |
| PharmAust Limited | 6.65 Million AUD | -494.479% |
| Hexima Limited | 1 Million AUD | -3823.114% |
| AnteoTech Limited | 12.18 Million AUD | -224.726% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 39.213% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -82.501% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -770.649% |
| Actinogen Medical Limited | 22.77 Million AUD | -73.797% |
| Immuron Limited | 9.13 Million AUD | -333.079% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -378.579% |